Eden Research plc (AIM: EDEN)

Market Cap	21.07M
Revenue (ttm)	3.94M
Net Income (ttm)	-1.52M
Shares Out	533.35M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,549
Open	4.050
Previous Close	3.850
Day's Range	3.855 - 4.050
52-Week Range	3.300 - 7.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About Eden Research

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray pro...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1995
• Employees: 19
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EDEN

Financial Performance

In 2023, Eden Research's revenue was 3.19 million, an increase of 74.70% compared to the previous year's 1.83 million. Losses were -6.49 million, 190.3% more than in 2022.